Approval · Notice of Compliance 4535 · 1996
MEGESTROL: Notice of Compliance 4535
Issued June 10, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4535
- Date
- June 10, 1996
- Company
- Laboratoires Pro Doc Limitée
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Oral progestogen, antineoplastic
Products in this notice
Medicinal ingredients
- MEGESTROL ACETATE 40 MG per TAB
- MEGESTROL ACETATE 160 MG per TAB